MetLife Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $161K | Sell |
|
|||||
|
2025
Q2 | $155K | Buy |
|
|||||
|
2025
Q1 | $151K | Buy |
|
|||||
|
2024
Q4 | $132K | Sell |
|
|||||
|
2024
Q3 | $155K | Hold |
|
|||||
|
2024
Q2 | $187K | Buy |
|
|||||
|
2024
Q1 | $122K | Sell |
|
|||||
|
2023
Q4 | $129K | Hold |
|
|||||
|
2023
Q3 | $132K | Hold |
|
|||||
|
2023
Q2 | $202K | Hold |
|
|||||
|
2023
Q1 | $208K | Hold |
|
|||||
|
2022
Q4 | $226K | Hold |
|
|||||
|
2022
Q3 | $302K | Hold |
|
|||||
|
2022
Q2 | $334K | Hold |
|
|||||
|
2022
Q1 | $346K | Buy |
|
|||||
|
2021
Q4 | $308K | Buy |
|
|||||
|
2021
Q3 | $280K | Sell |
|
|||||
|
2021
Q2 | $460K | Hold |
|
|||||
|
2021
Q1 | $321K | Sell |
|
|||||
|
2020
Q4 | $320K | Hold |
|
|||||
|
2020
Q3 | $235K | Hold |
|
|||||
|
2020
Q2 | $278K | Hold |
|
|||||
|
2020
Q1 | $252K | Hold |
|
|||||
|
2019
Q4 | $399K | Hold |
|
|||||
|
2019
Q3 | $323K | Hold |
|
|||||
|
2019
Q2 | $343K | Hold |
|
|||||
|
2019
Q1 | $448K | Hold |
|
|||||
|
2018
Q4 | $636K | Hold |
|
|||||
|
2018
Q3 | $559K | Hold |
|
|||||
|
2018
Q2 | $464K | Buy |
|
|||||
|
2018
Q1 | $342K | Hold |
|
|||||
|
2017
Q4 | $308K | Buy |
|